SP
Therapeutic Areas
Qbiotics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Tigilanol tiglate | Soft tissue sarcoma, head and neck cancers | Phase 2 |
| EBC-1013 | Venous leg ulcers (chronic wounds) | Phase 1 |
| Antibiotic discovery programme | Bacterial virulence inhibition | Preclinical |